Tirzepatide availability over the Next Six Months

In light of ongoing developments surrounding GLP-1 medications like Mounjaro and Zepbound, we want to update you on our approach to maintaining access to tirzepatide. As highlighted recently, there have been significant disruptions in the availability of these medications. However, we are actively working with compounding pharmacies to ensure that we can meet patient needs and avoid the common hurdles seen in recent months.

We are pleased to report that, despite the broader concerns, we expect to have consistent availability of tirzepatide for the next six months. This allows us to continue shipping uninterrupted and provide ongoing care for our clients.

If, however, we encounter supply issues beyond that period, we have arrangements with partner pharmacies in Canada to secure alternative options. This partnership ensures that even in the face of further disruptions, we can continue delivering medication reliably.

In the unlikely scenario that these backup plans are exhausted, we want to remind our clients that we only charge a simple monthly fee. There are no initiation fees, hidden charges, or extra costs. Our pricing model remains transparent, and you will not be left paying more if external factors affect the supply chain.

We remain committed to providing you with the highest level of care, with as little interruption as possible. Thank you for your continued trust in our service.